Laparoscopic Radioisotope-Guided Sentinel Lymph Node Dissection in Staging of Prostate Cancer

European Urology

Volumn 53, Issue 1, 2008, Pages 126-133

  Jeschke, Stephan ^a   Beri, Avi ^a   Grüll, Martin ^a   Ziegerhofer, Josef ^a   Prammer, Peter ^a   Leeb, Karl ^a   Sega, Wolfgang ^b   Janetschek, Guenter ^a  

^a ELISABETHINEN HOSPITAL   (Austria)

^b Krankenhaus der Barmherzigen Schwestern Wien Betriebsgesellschaft   (Austria)

Author keywords

Laparoscopy; Lymphatic metastases; Prostatectomy; Prostatic neoplasm; Sentinel lymph node

Indexed keywords

ALBUMIN TC 99M; PROSTATE SPECIFIC ANTIGEN; SENTI SCINT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER SIZE; CANCER STAGING; FROZEN SECTION; HUMAN; HUMAN TISSUE; LAPAROSCOPY; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSTATE CANCER; RELIABILITY; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE BIOPSY;

AGED; ENDOSONOGRAPHY; FOLLOW-UP STUDIES; HUMANS; INJECTIONS, INTRALESIONAL; LAPAROSCOPY; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PELVIS; PREOPERATIVE CARE; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; TECHNETIUM TC 99M AGGREGATED ALBUMIN;

EID: 36448949399     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2007.03.064     Document Type: Article

References (24)

1. Allaf M.E., Palapattu G.S., Trock B.J., Carter H.B., and Walsh P.C. Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancer. J Urol 5 (2004) 1840-1844
2. Bader P., Burkhard F.C., Markwalder R., and Studer U.E. Is a limited lymph node dissection an adequate staging procedure for prostate cancer?. J Urol 168 (2002) 514-518
3. Clark T., Parekh D.J., Cookson M.S., Chang S.S., Smith Jr. E.R., and Wells N. Randomized prospective evaluation of extended versus limited lymph node dissection in patients with clinically localized prostate cancer. J Urol 169 (2003) 145-147
4. Briganti A., Chun F.K.-H., Salonia A., et al. Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer. Eur Urol 50 (2006) 1006-1013
5. Wawroschek F., Vogt H., Wengenmair H., et al. Prostate lymphoscintigraphy and radio-guided surgery for sentinel lymph node identification in prostate cancer. Technique and results of the first 350 cases. Urol Int 4 (2003) 303-310
6. Jeschke S., Nambirajan T., Ziegerhofer J., Sega W., and Janetschek G. Detection of early lymph node metastases in prostate cancer by laparoscopic radioisotope guided sentinel lymph node dissection. J Urol 6 (2005) 1943-1946
7. Cabanas R.M. An approach for the treatment of penile carcinoma. Cancer 39 (1977) 456-466
8. Pettaway C.A., Pisters L.L., Dinney C.P., et al. Sentinel lymph node dissection for penile carcinoma: the M.D. Anderson Cancer Center experience. J Urol 6 (1995) 1999-2003
9. Alex J.C., and Krag D.N. Gamma-probe guided localization of lymph nodes. Surg Oncol 2 (1993) 137-143
10. Paganelli G., De Cicco C., Cremonesi M., et al. Optimized sentinel node scintigraphy in breast cancer. Q J Nucl Med 1 (1998) 49-53
11. Takashima H., Egawa M., Imao T., Fukuda M., Yokoyama K., and Namiki M. Validity of sentinel lymph node concept for patients with prostate cancer. J Urol 6 (2004) 2268-2271
12. Brenot Rossi I., Bastide C., Garcia S., et al. Limited pelvic lymphadenectomy using the sentinel lymph node procedure in patients with localised prostate carcinoma: a pilot study. Eur J Nucl Med Mol Imaging 6 (2005) 635-640
13. Raghavaiah N.V., and Jordan W.R. Prostatic lymphography. J Urol 2 (1979) 178-181
14. Brossner C., Ringhofer H., Hernady T., Kuber W., Madersbacher S., and Pycha A. Lymphatic drainage of prostatic transition and peripheral zones visualized on a three-dimensional workstation. Urology 2 (2001) 389-393
15. Wawroschek F., Wengenmair H., Senekowitsch-Schmidtke R., et al. Prostate lymphoscintigraphy for sentinel lymph node identification in canines: reproducibility, uptake, and biokinetics depending on different injection strategies. Urol Res 3 (2003) 152-158
16. Cerny J.C., Farah R., Rian R., and Weckstein M.L. An evaluation of lymphangiography in staging carcinoma of the prostate. J Urol 3 (1975) 367-370
17. Golimbu M., Morales P., Al-Askari S., and Brown J. Extended pelvic lymphadenectomy for prostatic cancer. J Urol 5 (1979) 617-620
18. Mattei A, Warncke SH, Fuechsel F, Brun SZ, Krause T, Studer UE. Number of prostatic sentinel lymph nodes outside of the areas of "limited" versus "extended" pelvic dissection. Scientific program of the 21st Annual Congress of the European Association of Urology. Abstract 614.
19. Corvin S., Schilling D., Eichhorn K., et al. Laparoscopic sentinel lymph node dissection - a novel technique for the staging of prostate cancer. Eur Urol 49 (2006) 280-285
20. Häcker A., Jeschke S., Leeb K., et al. Detection of pelvic lymph node metastases in patients with clinically localized prostate cancer: comparison of FCH PET/CT and laparoscopic radioisotope-guided sentinel lymph node dissection. J Urol 176 (2006) 2014-2018 discussion 2018-9
21. Pound C.R., Partin A.W., Epstein J.I., and Walsh P.C. Prostate-specific antigen after anatomic radical retropubic prostatectomy. Urol Clin North Am 24 (1997) 395-406
22. Catalona W.J., and Smith D.S. Cancer recurrence and survival rates after anatomic radical retropubic prostatectomy for prostate cancer: intermediate-term results. J Urol 160 (1998) 2428-2434
23. Partin A.W., Kattan M.W., Subong E.N.P., et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. JAMA 277 (1997) 1445-1451
24. Bishoff J.T., Reyes A., Thompson I.M., et al. Pelvic lymphadenectomy can be omitted in selected patients with carcinoma of the prostate: development of a system of patient selection. Urology 45 (1995) 270-274